JCR Pharmaceuticals (Japan)
- World rank, all time
- #28,494 of 42,892
- Rank in Japan
- #1,158 of 2,112
- Research works
- 136 ▲ 216% vs 2013–17
- Citations
- 5.2k 38.2 per fractional work
- Top-10% rate
- 16.2% record average 16.5%
- Open access
- 45% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.5×. Every wedge is a field page.
Who are the top researchers at JCR Pharmaceuticals (Japan)?
Ranked on the composite score, Kohtaro Minami and Hiroyuki Sonoda lead among researchers whose main affiliation is JCR Pharmaceuticals (Japan).
- 1 Kohtaro Minami Japan · #863,707 worldwide 62 citations · 23 works
- 2 Hiroyuki Sonoda Japan · #1,089,174 worldwide 31 citations · 19 works
Which keywords describe research at JCR Pharmaceuticals (Japan)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer, Parkinson's Disease, Enzyme Replacement Therapy, Lysosomal Storage Disorders, Inflammation, Metabolism, Genetic Mutations and Angiogenesis.
- Neuroendocrine Control
- Mechanotransduction
- Cell Adhesion
- Oligosaccharide Synthesis
- Growth Hormone
- Chagas Disease
- Virulence Factors
- Extracellular Matrix Remodeling
- Synaptic Plasticity
- Monoclonal Antibodies
- Metastasis
- Hemostasis
- Cancer Progression
- Myoclonic Disorders
- Neurodegeneration
- Extracellular Matrix
- Genetic Mutations
- Epidemiology
- Enzyme Replacement Therapy
- Cancer
- Inflammation
- Parkinson's Disease
- Lysosomal Storage Disorders
- Metabolism
- Angiogenesis
- Cell Signaling
- Glycogen
- Stem Cells
- Glycosylation
- Drug Resistance
- Antioxidant Activity
- Matrix Metalloproteinases
- Toll-like Receptors
- Tissue Inhibitors of Metalloproteinases
- Vector Control
- Glycosidase Inhibitors
- Mitochondrial Dysfunction
- Trypanosoma cruzi
- Therapeutic Antibodies
- Dendritic Spines
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation14▲ 4.3×24 topics
- Cancer12▲ 6.4×15 topics
- Parkinson's Disease11▲ 36×3 topics
- Enzyme Replacement Therapy11▲ 291×1 topic
- Lysosomal Storage Disorders11▲ 403×1 topic
- Epidemiology10▲ 1.90×18 topics
- Metabolism10▲ 11×7 topics
- Genetic Mutations9▲ 13×10 topics
- Angiogenesis9▲ 16×8 topics
- Extracellular Matrix8▲ 23×4 topics
- Cell Signaling7▲ 15×7 topics
- Neurodegeneration7▲ 16×4 topics
- Glycogen6▲ 288×1 topic
- Myoclonic Disorders6▲ 288×1 topic
- Stem Cells6▲ 14×6 topics
- Cancer Progression6▲ 18×4 topics
- Glycosylation5▲ 17×3 topics
- Hemostasis4▲ 19×3 topics
- Drug Resistance4▲ 8.3×2 topics
- Metastasis4▲ 7.9×3 topics
- Antioxidant Activity4▲ 4.7×9 topics
- Monoclonal Antibodies4▲ 18×3 topics
- Matrix Metalloproteinases3▲ 16×2 topics
- Synaptic Plasticity3▲ 8.0×3 topics
- Toll-like Receptors3▲ 15×3 topics
- Extracellular Matrix Remodeling3▲ 70×1 topic
- Tissue Inhibitors of Metalloproteinases3▲ 70×1 topic
- Virulence Factors3▲ 13×3 topics
- Vector Control3▲ 20×2 topics
- Chagas Disease3▲ 84×1 topic
- Glycosidase Inhibitors3▲ 45×1 topic
- Growth Hormone3▲ 27×2 topics
- Mitochondrial Dysfunction3▲ 6.2×8 topics
- Oligosaccharide Synthesis3▲ 45×1 topic
- Trypanosoma cruzi3▲ 84×1 topic
- Cell Adhesion3▲ 24×2 topics
- Therapeutic Antibodies3▲ 16×2 topics
- Mechanotransduction3▲ 20×3 topics
- Dendritic Spines3▲ 12×2 topics
- Neuroendocrine Control3▲ 29×2 topics
Which research topics does JCR Pharmaceuticals (Japan) publish most on?
By volume in 2022–2025: Lysosomal Storage Disorders Research, Glycogen Storage Diseases and Myoclonus, Carbohydrate Chemistry and Synthesis and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lysosomal Storage Disorders Research Physiology 3 works
- 2 Glycogen Storage Diseases and Myoclonus Rheumatology 2 works
- 3 Carbohydrate Chemistry and Synthesis Organic Chemistry 1 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 5 Neonatal and fetal brain pathology Pediatrics, Perinatology and Child Health 0 works
- 6 Fetal and Pediatric Neurological Disorders Pediatrics, Perinatology and Child Health 0 works
- 7 Trypanosoma species research and implications Epidemiology 0 works
- 8 Blood Coagulation and Thrombosis Mechanisms Hematology 0 works
- 9 Chemical Synthesis and Reactions Organic Chemistry 0 works
- 10 Retinal Development and Disorders Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has JCR Pharmaceuticals (Japan)'s research output changed?
Output in 2018–2022 was 216% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Ashiya
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.